Efficacy and safety results of a randomized, double-blind, vehicle-controlled phase 2 study of roflumilast foam 0.3% in patients with seborrheic dermatitis
被引:0
|
作者:
Zirwas, M.
论文数: 0引用数: 0
h-index: 0
机构:
Prob Med Res, Dermatologists Cent States, Bexley, OH USA
Ohio Univ, Bexley, OH USAProb Med Res, Dermatologists Cent States, Bexley, OH USA
Zirwas, M.
[1
,2
]
机构:
[1] Prob Med Res, Dermatologists Cent States, Bexley, OH USA
[2] Ohio Univ, Bexley, OH USA
[3] Arcutis Biotherapeut Inc, Westlake Village, CA USA
机构:
COLUMBIA PRESBYTERIAN MED CTR,DEPT DERMATOL,NAIL RES CTR,NEW YORK,NY 10032COLUMBIA PRESBYTERIAN MED CTR,DEPT DERMATOL,NAIL RES CTR,NEW YORK,NY 10032
MONTANA, JB
SCHER, RK
论文数: 0引用数: 0
h-index: 0
机构:
COLUMBIA PRESBYTERIAN MED CTR,DEPT DERMATOL,NAIL RES CTR,NEW YORK,NY 10032COLUMBIA PRESBYTERIAN MED CTR,DEPT DERMATOL,NAIL RES CTR,NEW YORK,NY 10032